Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analyses.
暂无分享,去创建一个
Michael Hardisty | Mark Clemons | Parminder S Basran | M. Hardisty | M. Clemons | P. Basran | Tomas Skrinskas | Lyle Gordon | T. Skrinskas | Carl Whyne | Florence Wu | L. Gordon | F. wu | C. Whyne
[1] R. Rubens,et al. Bone metastases--the clinical problem. , 1998, European journal of cancer.
[2] G D Roodman,et al. Biology of osteoclast activation in cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] G. Cs,et al. Skeletal metastases and mammary cancer. , 1972 .
[4] G. Hortobagyi,et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] DAVID A. WONG,et al. Spinal Metastases: The Obvious, the Occult, and the Impostors , 1990, Spine.
[6] J. Rubenstein,et al. Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy--a feasibility study. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] G. Hortobagyi,et al. Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy , 1984, Cancer.
[8] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer (an amendment) , 1978, British Journal of Cancer.
[9] Yeu‐Tsu N. Lee,et al. Bone scanning in patients with early breast carcinoma: Should it be a routine staging procedure? , 1981, Cancer.
[10] Naoto T Ueno,et al. Bone imaging in metastatic breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] R. Coleman. Monitoring of bone metastases. , 1998, European journal of cancer.
[12] D. Dershaw,et al. Imaging techniques in breast cancer. , 1989, Seminars in surgical oncology.
[13] R E O'Mara,et al. Skeletal scanning in neoplastic disease , 1976, Cancer.
[14] W. Greig,et al. A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. , 1977, Clinical radiology.
[15] M. Sundaram,et al. Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor-like lesion of bone? , 2004, Skeletal Radiology.
[16] F. Doyle,et al. The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. , 1972, Clinical radiology.
[17] I. Fogelman,et al. The role of positron emission tomography in the management of bone metastases , 2000, Cancer.
[18] R. Coleman,et al. The management of bone metastases. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] J H Thrall,et al. Solitary abnormalities in bone scans of patients with extraosseous malignancies. , 1976, Radiology.
[20] R. Rubens,et al. Reappraisal of the baseline bone scan in breast cancer. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] N. Janjan. Bone metastases: approaches to management. , 2001, Seminars in oncology.
[22] T. Powles,et al. The role of computed tomography in the detection of bone metastases in breast cancer patients. , 1983, The British journal of radiology.
[23] G. Hortobagyi,et al. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] R. Rubens,et al. The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.
[25] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.
[26] D. Kido,et al. Comparative sensitivity of CT scans, radiographs and radionuclide bone scans in detecting metastatic calvarial lesions. , 1978, Radiology.
[27] R. Daffner,et al. MRI in the detection of malignant infiltration of bone marrow. , 1986, AJR. American journal of roentgenology.
[28] C. Whyne,et al. Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method. , 2007, Medical physics.
[29] B. A. Goddard,et al. Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging. , 1981, The British journal of radiology.
[30] M. Tubiana-Hulin,et al. Incidence, prevalence and distribution of bone metastases. , 1991, Bone.
[31] Bonnie N Joe,et al. Adrenal masses: CT characterization with histogram analysis method. , 2003, Radiology.
[32] Takashi Ohtsuka,et al. Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness. , 2003, The Journal of thoracic and cardiovascular surgery.
[33] T. Sanders,et al. Radiographic imaging of musculoskeletal neoplasia. , 2001, Cancer control : journal of the Moffitt Cancer Center.
[34] C. Galasko. The value of scintigraphy in malignant disease. , 1975, Cancer treatment reviews.
[35] R. Eastell,et al. Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. , 1996, Cancer treatment reviews.
[36] L. Rybak,et al. Radiological imaging for the diagnosis of bone metastases. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[37] G. Edelstyn,et al. The radiological demonstration of osseous metastases. Experimental observations. , 1967, Clinical radiology.
[38] P. LoRusso. Analysis of skeletal-related events in breast cancer and response to therapy. , 2001, Seminars in oncology.
[39] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.